1H NMR-based metabolomic analysis for identifying serum biomarkers to evaluate methotrexate treatment in patients with early rheumatoid arthritis
Zhigang Wang(Brigham and Women's Hospital), Shenghao Tu(Hsin Sheng College of Medical Care and Management), Li-Fang Yu(Wuhan General Hospital of Guangzhou), Zhiguo Rao(Lanzhou University), Sisi Yang(Zhejiang University), Yu Wang(Shanghai East Hospital), Zhe Chen(Southwest University of Science and Technology), Jianfei Gao(Shenyang Pharmaceutical University), Bicheng Zhang(University of Electronic Science and Technology of China)
Cited by 73
Related Papers
Clinical characteristics of 82 cases of death from COVID-19
|PLoS ONE|2020|594
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
|Frontiers in Molecular Biosciences|2020|497
Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019
|Clinical Infectious Diseases|2020|458
Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis
|Journal of Hepatology|2021|378
Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
|Frontiers in Immunology|2020|256